Rheumatoid arthritis synoviocyte survival is dependent on Stat3

Journal of Immunology

Volumn 169, Issue 11, 2002, Pages 6610-6616

  Krause, Anja ^a   Scaletta, Nicholas ^a   Ji, Jong Dae ^a   Ivashkiv, Lionel B ^a,b,c  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b Weill Cornell Graduate School of Biomedical Sciences   (United States)

^c HOSPITAL FOR SPECIAL SURGERY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; DNA; EPIDERMAL GROWTH FACTOR; GROWTH FACTOR; INTERLEUKIN 6; LIPOCORTIN 5; PLATELET DERIVED GROWTH FACTOR; PROPIDIUM IODIDE; STAT3 PROTEIN; DNA BINDING PROTEIN; STAT3 PROTEIN, HUMAN; TRANSACTIVATOR PROTEIN;

APOPTOSIS; ARTICLE; CELL GROWTH; CELL SURVIVAL; CONTROLLED STUDY; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER; HUMAN; HUMAN CELL; ONCOGENE; ONCOGENE MYC; ONCOGENE SOCS3; OSTEOARTHRITIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SYNOVIOCYTE; SYNOVITIS; CELL CULTURE; CELL DIVISION; DRUG ANTAGONISM; DRUG EFFECT; GENETIC TRANSDUCTION; GENETICS; IMMUNOLOGY; METABOLISM; PATHOLOGY; SYNOVIUM;

APOPTOSIS; ARTHRITIS, RHEUMATOID; CELL DIVISION; CELL SURVIVAL; CELLS, CULTURED; DNA-BINDING PROTEINS; EPIDERMAL GROWTH FACTOR; HUMANS; STAT3 TRANSCRIPTION FACTOR; SYNOVIAL MEMBRANE; TRANS-ACTIVATORS; TRANSDUCTION, GENETIC;

EID: 0036884944     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.169.11.6610     Document Type: Article

References (46)

1. Feldmann, M., F. M. Brennan, and R. N. Maini. 1996. Role of cytokines in rheumatoid arthritis. Annu. Rev. Immunol. 14:397.
2. Ivashkiv, L. B. 1996. Cytokine expression and cell activation in inflammatory arthritis. Adv. Immunol. 63:337.
3. Muller-Ladner, U., R. E. Gay, and S. Gay. 1998. Molecular biology of cartilage and bone destruction. Curr. Opin. Rheumatol. 10:212.
4. Pap, T., U. Muller-Ladner, R. E. Gay, and S. Gay. 2000. Fibroblast biology: role of synovial fibroblasts in the pathogenesis of rheumatoid arthritis. Arthritis Res. 2:361.
5. Yamanishi, Y., and G. S. Firestein. 2001. Pathogenesis of rheumatoid arthritis: the role of synoviocytes. Rheum. Dis. Clin. North Am. 27:355.
6. Firestein, G. S., and N. J. Zvaifler. 1990. How important are T cells in chronic rheumatoid synovitis? [Published erratum appears in 1990 Arthritis Rheum. 33:1437.]. Arthritis Rheum. 33:768.
7. Lafyatis, R., E. F. Remmers, A. B. Roberts, D. E. Yocum, M. B. Sporn, and R. L. Wilder. 1989. Anchorage-independent growth of synoviocytes from arthritic and normal joints: stimulation by exogenous platelet-derived growth factor and inhibition by transforming growth factor-β and retinoids. J. Clin. Invest. 83:1267.
8. Mountz, J. D., and H. G. Zhang. 2001. Regulation of apoptosis of synovial fibroblasts. Curr. Dir. Autoimmun. 3:216.
9. Bucala, R., C. Ritchlin, R. Winchester, and A. Cerami. 1991. Constitutive production of inflammatory and mitogenic cytokines by rheumatoid synovial fibroblasts. J. Exp. Med. 173:569.
10. Satoh, K., S. Kikuchi, M. Sekimata, Y. Kabuyama, M. K. Homma, and Y. Homma. 2001. Involvement of ErbB-2 in rheumatoid synovial cell growth. Arthritis Rheum. 44:260.
11. Aupperle, K. R., D. L. Boyle, M. Hendrix, E. A. Seftor, N. J. Zvaifler, M. Barbosa, and G. S. Firestein. 1998. Regulation of synoviocyte proliferation, apoptosis, and invasion by the p53 tumor suppressor gene. Am. J. Pathol. 152:1091.
12. Muller-Ladner, U., J. Kriegsmann, B. N. Franklin, S. Matsumoto, T. Geiler, R. E. Gay, and S. Gay. 1996. Synovial fibroblasts of patients with rheumatoid arthritis attach to and invade normal human cartilage when engrafted into SCID mice. Am. J. Pathol. 149:1607.
13. INK4a senescence gene as a new therapeutic strategy for the treatment of rheumatoid arthritis. Nat. Med. 5:760.
14. Darnell, J. E., Jr. 1997. STATs and gene regulation. Science 277:1630.
15. O'Shea, J. J. 1997. Jaks, STATS, cytokine signal transduction, and immunoregulation: are we there yet? [Published erratum appears in 1997 Immunity 7:444.]. Immunity 7:1.
16. Wang, F., T. K. Sengupta, Z. Zhong, and L. B. Ivashkiv. 1995. Regulation of the balance of cytokine production and the signal transducer and activator of transcription (STAT) transcription factor activity by cytokines and inflammatory synovial fluids. J. Exp. Med. 182:1825.
17. Shouda, T., T. Yoshida, T. Hanada, T. Wakioka, M. Oishi, K. Miyoshi, S. Komiya, K. Kosai, Y. Hanakawa, K. Hashimoto, et al. 2001. Induction of the cytokine signal regulator SOCS3/CIS3 as a therapeutic strategy for treating inflammatory arthritis. J. Clin. Invest. 108:1781.
18. Bromberg, J. F., M. H. Wrzeszczynska, G. Devgan, Y. Zhao, R. G. Pestell, C. Albanese, and J. E. Darnell. 1999. Stat3 as an oncogene. Cell 98:295.
19. Chaturvedi, P., S. Sharma, and E. P. Reddy. 1997. Abrogation of interleukin-3 dependence of myeloid cells by the v-src oncogene requires SH2 and SH3 domains which specify activation of STATs. Mol. Cell. Biol. 17:3295.
20. Bromberg, J. F., C. M. Horvath, D. Besser, W. W. Lathem, and J. E. Darnell, Jr. 1998. Stat3 activation is required for cellular transformation by v-src. Mol. Cell. Biol. 18:2553.
21. Turkson, J., T. Bowman, R. Garcia, E. Caldenhoven, R. P. De Groot, and R. Jove. 1998. Stat3 activation by Src induces specific gene regulation and is required for cell transformation. Mol. Cell. Biol. 18:2545.
22. Shirogane, T., T. Fukada, J. M. Muller, D. T. Shima, M. Hibi, and T. Hirano. 1999. Synergistic roles for Pim-1 and c-Myc in STAT3-mediated cell cycle progression and antiapoptosis. Immunity 11:709.
23. Lee, I. H., W. P. Li, K. B. Hisert, and L. B. Ivashkiv. 1999. Inhibition of interleukin 2 signaling and signal transducer and activator of transcription (STAT)5 activation during T cell receptor-mediated feedback inhibition of T cell expansion. J. Exp. Med. 190:1263.
24. Riviere, I., K. Brose, and R. C. Mulligan. 1995. Effects of retroviral vector design on expression of human adenosine deaminase in murine bone marrow transplant recipients engrafted with genetically modified cells. Proc. Natl. Acad. Sci. USA 92:6733.
25. Ory, D. S., B. A. Neugeboren, and R. C. Mulligan. 1996. A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes. Proc. Natl. Acad. Sci. USA 93:11400.
26. Miller, A. D., J. V. Garcia, N. von Suhr, C. M. Lynch, C. Wilson, and M. V. Eiden. 1991. Construction and properties of retrovirus packaging cells based on gibbon ape leukemia virus. J. Virol. 65:2220.
27. Krause, A., H. F. Guo, J. B. Latouche, C. Tan, N. K. Cheung, and M. Sadelain. 1998. Antigen-dependent CD28 signaling selectively enhances survival and proliferation in genetically modified activated human primary T lymphocytes. J. Exp. Med. 188:619.
28. Castro, A., T. K. Sengupta, D. C. Ruiz, E. Yang, and L. B. Ivashkiv. 1999. IL-4 selectively inhibits IL-2-triggered Stat5 activation, but not proliferation, in human T cells. J. Immunol. 162:1261.
29. Deon, D., S. Ahmed, K. Tai, N. Scaletta, C. Herrero, I. H. Lee, A. Krause, and L. B. Ivashkiv. 2001. Cross-talk between IL-1 and IL-6 signaling pathways in rheumatoid arthritis synovial fibroblasts. J. Immunol. 167:5395.
30. Yasukawa, H., A. Sasaki, and A. Yoshimura. 2000. Negative regulation of cytokine signaling pathways. Annu. Rev. Immunol. 18:143.
31. Nishimoto, N., A. Ito, M. Ono, H. Tagoh, T. Matsumoto, T. Tomita, T. Ochi, and K. Yoshizaki. 2000. IL-6 inhibits the proliferation of fibroblastic synovial cells from rheumatoid arthritis patients in the presence of goluble IL-6 receptor. Int. Immunol. 12:187.
32. Bromberg, J. F., Z. Fan, C. Brown, J. Mendelsohn, and J. E. Darnell. 1998. Epidermal growth factor-induced growth inhibition requires Stat1 activation. Cell Growth Differ. 9:505.
33. Tak, P. P., and G. S. Firestein. 2001. NF-κB: a key role in inflammatory diseases. J. Clin. Invest. 107:7.
34. Suzuki, A., T. Hanada, K. Mitsuyama, T. Yoshida, S. Kamizono, T. Hoshino, M. Kubo, A. Yamashita, M. Okabe, K. Takeda, et al. 2001. CIS3/SOCS3/SSI3 plays a negative regulatory role in STAT3 activation and intestinal inflammation. J. Exp. Med. 193:471.
35. Catlett-Falcone, R., T. H. Landowski, M. M. Oshiro, J. Turkson, A. Levitzki, R. Savino, G. Ciliberto, L. Moscinski, J. L. Fernandez-Luna, G. Nunez, et al. 1999. Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells. Immunity 10:105.
36. Epling-Burnette, P. K., J. H. Liu, R. Catlett-Falcone, J. Turkson, M. Oshiro, R. Kothapalli, Y. Li, J. M. Wang, H. F. Yang-Yen, J. Karras, et al. 2001. Inhibition of STAT3 signaling leads to apoptosis of leukemic large granular lymphocytes and decreased Mcl-1 expression. J. Clin. Invest. 107:351.
37. Grandis, J. R., S. D. Drenning, Q. Zeng, S. C. Watkins, M. F. Melhem, S. Endo, D. E. Johnson, L. Huang, Y. He, and J. D. Kim. 2000. Constitutive activation of Stat3 signaling abrogates apoptosis in squamous cell carcinogenesis in vivo. Proc. Natl. Acad. Sci. USA 97:4227.
38. Ivanov, V. N., A. Bhoumik, M. Krasilnikov, R. Raz, L. B. Owen-Schaub, D. Levy, C. M. Horvath, and Z. Ronai. 2001. Cooperation between STAT3 and c-jun suppresses Fas transcription. Mol. Cell 7:517.
39. Baldwin, A. S., Jr. 1996. The NF-κB and IκB proteins: new discoveries and insights. Annu. Rev. Immunol. 14:649.
40. Shen, Y., G. Devgan, J. E. Darnell, and J. F. Bromberg. 2001. Constitutively activated Stat3 protects fibroblasts from serum withdrawal and UV-induced apoptosis and antagonizes the proapoptotic effects of activated Stat1. Proc. Natl. Acad. Sci. USA 98:1543.
41. Shankaran, V., H. Ikeda, A. T. Bruce, J. M. White, P. E. Swanson, L. J. Old, and R. D. Schreiber. 2001. IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity. Nature 410:1107.
42. Pap, T., U. Muller-Ladner, R. Gay, and S. Gay. 1999. Gene therapy in rheumatoid arthritis: how to target joint destruction? Arthritis Res. 1:5.
43. van den Berg, W. B. 2001. Uncoupling of inflammatory and destructive mechanisms in arthritis. Semin. Arthritis Rheum. 30:7.
44. Franz, J. K., T. Pap, K. M. Hummel, M. Nawrath, W. K. Aicher, Y. Shigeyama, U. Muller-Ladner, R. E. Gay, and S. Gay. 2000. Expression of sentrin, a novel antiapoptotic molecule, at sites of synovial invasion in rheumatoid arthritis. Arthritis Rheum. 43:599.
45. Zhang, H. G., Y. Wang, J. F. Xie, X. Liang, D. Liu, P. Yang, H. C. Hsu, R. B. Ray, and J. D. Mountz. 2001. Regulation of tumor necrosis factor α-mediated apoptosis of rheumatoid arthritis synovial fibroblasts by the protein kinase Akt. Arthritis Rheum. 44:1555.
46. Miagkov, A. V., D. V. Kovalenko, C. E. Brown, J. R. Didsbury, J. P. Cogswell, S. A. Stimpson, A. S. Baldwin, and S. S. Makarov. 1998. NF-κB activation provides the potential link between inflammation and hyperplasia in the arthritic joint. Proc. Natl. Acad. Sci. USA 95:13859.